Your Search for 'Simcere Pharmaceuticals Generics Company Intelligence Report' returned 1 results - Page 1 of 1

• Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market

  EURO€ 2,690.00USD$ 3,500.00GBP£ 2,263.00AUD$ 3,423.00JPY¥ 345,565.00SEK 22 980,00CHF 3'299.00CAD$ 3,566.00 GBI Research, Jan 2011 , Pages: 122
  top five players occupying only 29% of the entire market. There is only one Chinese company, Simcere, which found a place in the top five players, with 5% of the market share, third highest after Roche ...